These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
237 related articles for article (PubMed ID: 31496691)
1. Poly(lactic-co-glycolic acid) nanoparticle-mediated interleukin-12 delivery for the treatment of diabetic retinopathy. Zeng L; Ma W; Shi L; Chen X; Wu R; Zhang Y; Chen H; Chen H Int J Nanomedicine; 2019; 14():6357-6369. PubMed ID: 31496691 [TBL] [Abstract][Full Text] [Related]
2. Fenofibrate-Loaded Biodegradable Nanoparticles for the Treatment of Experimental Diabetic Retinopathy and Neovascular Age-Related Macular Degeneration. Qiu F; Meng T; Chen Q; Zhou K; Shao Y; Matlock G; Ma X; Wu W; Du Y; Wang X; Deng G; Ma JX; Xu Q Mol Pharm; 2019 May; 16(5):1958-1970. PubMed ID: 30912953 [TBL] [Abstract][Full Text] [Related]
3. Neuroprotective effect of insulin-loaded chitosan nanoparticles/PLGA-PEG-PLGA hydrogel on diabetic retinopathy in rats. Rong X; Ji Y; Zhu X; Yang J; Qian D; Mo X; Lu Y Int J Nanomedicine; 2019; 14():45-55. PubMed ID: 30587984 [TBL] [Abstract][Full Text] [Related]
4. Chitosan coated nanoparticles for efficient delivery of bevacizumab in the posterior ocular tissues via subconjunctival administration. Pandit J; Sultana Y; Aqil M Carbohydr Polym; 2021 Sep; 267():118217. PubMed ID: 34119171 [TBL] [Abstract][Full Text] [Related]
5. Intravitreal Delivery of VEGF-A Mezu-Ndubuisi OJ; Wang Y; Schoephoerster J; Falero-Perez J; Zaitoun IS; Sheibani N; Gong S Curr Eye Res; 2019 Mar; 44(3):275-286. PubMed ID: 30383455 [TBL] [Abstract][Full Text] [Related]
6. Anisotropic poly(lactic-co-glycolic acid) microparticles enable sustained release of a peptide for long-term inhibition of ocular neovascularization. Kim J; Lima E Silva R; Shmueli RB; Mirando AC; Tzeng SY; Pandey NB; Ben-Akiva E; Popel AS; Campochiaro PA; Green JJ Acta Biomater; 2019 Oct; 97():451-460. PubMed ID: 31374338 [TBL] [Abstract][Full Text] [Related]
7. Sustained delivery of vascular endothelial growth factor using a dextran/poly(lactic-co-glycolic acid)-combined microsphere system for therapeutic neovascularization. Zhang ZD; Xu YQ; Chen F; Luo JF; Liu CD Heart Vessels; 2019 Jan; 34(1):167-176. PubMed ID: 30043157 [TBL] [Abstract][Full Text] [Related]
8. A non-invasive nanoparticle mediated delivery of triamcinolone acetonide ameliorates diabetic retinopathy in rats. Mahaling B; Srinivasarao DA; Raghu G; Kasam RK; Bhanuprakash Reddy G; Katti DS Nanoscale; 2018 Sep; 10(35):16485-16498. PubMed ID: 29897081 [TBL] [Abstract][Full Text] [Related]
9. Efficiency co-delivery of ellagic acid and oxygen by a non-invasive liposome for ameliorating diabetic retinopathy. Li Z; Yu H; Liu C; Wang C; Zeng X; Yan J; Sun Y Int J Pharm; 2023 Jun; 641():122987. PubMed ID: 37207860 [TBL] [Abstract][Full Text] [Related]
11. Anti-Angiogenic Activity Of Bevacizumab-Bearing Dexamethasone-Loaded PLGA Nanoparticles For Potential Intravitreal Applications. Liu J; Zhang X; Li G; Xu F; Li S; Teng L; Li Y; Sun F Int J Nanomedicine; 2019; 14():8819-8834. PubMed ID: 31819410 [TBL] [Abstract][Full Text] [Related]
12. Blocking IL-17A Alleviates Diabetic Retinopathy in Rodents. Qiu AW; Liu QH; Wang JL Cell Physiol Biochem; 2017; 41(3):960-972. PubMed ID: 28222445 [TBL] [Abstract][Full Text] [Related]
13. Photoreceptor preservation induced by intravitreal controlled delivery of GDNF and GDNF/melatonin in rhodopsin knockout mice. García-Caballero C; Lieppman B; Arranz-Romera A; Molina-Martínez IT; Bravo-Osuna I; Young M; Baranov P; Herrero-Vanrell R Mol Vis; 2018; 24():733-745. PubMed ID: 30581280 [TBL] [Abstract][Full Text] [Related]
14. Attenuation of streptozotocin-induced diabetic retinopathy with low molecular weight fucoidan via inhibition of vascular endothelial growth factor. Yang W; Yu X; Zhang Q; Lu Q; Wang J; Cui W; Zheng Y; Wang X; Luo D Exp Eye Res; 2013 Oct; 115():96-105. PubMed ID: 23810809 [TBL] [Abstract][Full Text] [Related]
15. Enhancement of scutellarin oral delivery efficacy by vitamin B12-modified amphiphilic chitosan derivatives to treat type II diabetes induced-retinopathy. Wang J; Tan J; Luo J; Huang P; Zhou W; Chen L; Long L; Zhang LM; Zhu B; Yang L; Deng DY J Nanobiotechnology; 2017 Mar; 15(1):18. PubMed ID: 28249594 [TBL] [Abstract][Full Text] [Related]
16. Matrix metalloproteinase-14 is a biomarker of angiogenic activity in proliferative diabetic retinopathy. Abu El-Asrar AM; Mohammad G; Allegaert E; Ahmad A; Siddiquei MM; Alam K; Gikandi PW; De Hertogh G; Opdenakker G Mol Vis; 2018; 24():394-406. PubMed ID: 29853773 [TBL] [Abstract][Full Text] [Related]
17. Hyaluronic-Coated Albumin Nanoparticles for the Non-Invasive Delivery of Apatinib in Diabetic Retinopathy. Radwan SE; El-Kamel A; Zaki EI; Burgalassi S; Zucchetti E; El-Moslemany RM Int J Nanomedicine; 2021; 16():4481-4494. PubMed ID: 34239300 [TBL] [Abstract][Full Text] [Related]
18. Α-Melanocyte-Stimulating Hormone Protects Early Diabetic Retina from Blood-Retinal Barrier Breakdown and Vascular Leakage via MC4R. Cai S; Yang Q; Hou M; Han Q; Zhang H; Wang J; Qi C; Bo Q; Ru Y; Yang W; Gu Z; Wei R; Cao Y; Li X; Zhang Y Cell Physiol Biochem; 2018; 45(2):505-522. PubMed ID: 29402864 [TBL] [Abstract][Full Text] [Related]
19. Axitinib-Loaded Poly(Lactic-Co-Glycolic Acid) Nanoparticles for Age-Related Macular Degeneration: Formulation Development and Narvekar P; Bhatt P; Fnu G; Sutariya V Assay Drug Dev Technol; 2019; 17(4):167-177. PubMed ID: 31184962 [No Abstract] [Full Text] [Related]
20. Long-term retinal PEDF overexpression prevents neovascularization in a murine adult model of retinopathy. Haurigot V; Villacampa P; Ribera A; Bosch A; Ramos D; Ruberte J; Bosch F PLoS One; 2012; 7(7):e41511. PubMed ID: 22911805 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]